<DOC>
	<DOCNO>NCT01719146</DOCNO>
	<brief_summary>The purpose study prospectively collect data dos Erythropoietic Stimulating Agents Intravenous Iron , marker erythropoietic activity iron status . These data use derive mathematical model subsequently guide dose agent , desire therapeutic outcome achieve every patient , minimize patient exposure agent .</brief_summary>
	<brief_title>Prospective Observational Study Erythropoietin-Iron Interaction Anemia Renal Disease</brief_title>
	<detailed_description>Data collect 120 subject undergoing hemodialysis treatment 3 clinical site across United States ( 40 per site ) .5.5 mL blood specimen draw midweek treatment ( Wed/Thu ) measure : Hemoglobin Concentration Hematocrit Red Blood Cell Count Platelet Count Reticulocyte Percentage Reticulocyte Hemoglobin Mean Cellular Hemoglobin Mean Cellular Hemoglobin Concentration Mean Cell Volume Red Cell Volume Distribution Width Mean Platelet Volume Serum Iron Serum Ferritin Transferrin Saturation Hepcidin Soluble Transferrin Receptor Weekly ESA Iron dose deliver also record . From data : 1. mathematical model establish find biomarkers descriptive respect erythropoiesis-iron synergy , 2. mathematical model establish correlate iron dose iron marker .</detailed_description>
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Epoetin Alfa</mesh_term>
	<criteria>receive expect receive ESA life expectancy le 12 month frequent ( per month w/in last 6 month ) uncontrolled blood loss frequent ( per month w/in last 6 month ) hospitalization frequent ( per month w/in last 6 month ) access complication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Anemia</keyword>
	<keyword>Chronic Kidney Disease</keyword>
	<keyword>Erythropoiesis Stimulating Agents</keyword>
	<keyword>Erythropoietin</keyword>
	<keyword>Iron</keyword>
	<keyword>Iron Deficiency</keyword>
</DOC>